期刊文献+

不稳定性心绞痛患者血清生长分化因子15与TIMI危险评分的相关性 被引量:11

Correlation between serum growth differentiation factor-15 and TIMI risk scores in patients with unstable angina pectoris
下载PDF
导出
摘要 目的探讨不稳定性心绞痛(unstable angina pcetoris,UAP)患者血清生长分化因子15(GDF-15)与TIMI危险评分的相关性。方法采用酶联免疫吸附法(ELISA法)检测97例UA患者与30例健康体检者血清GDF-15的表达水平。采用TIMI危险评分方法将UA患者分为3组,比较各组间GDF-15表达水平差异。分析GDF-15与TIMI危险评分的相关性。结果 UA患者血清GDF-15的表达水平显著高于健康体检者,差异有统计学意义(P<0.01);不同TIMI危险评分分组之间血清GDF-15表达水平比较,差异有统计学意义(P<0.01);血清GDF-15表达水平与TIMI危险评分之间存在相关关系。结论血清GDF-15的表达水平可以作为UA患者危险分层评估指标。 Objective To explore the correlation between serum levels of growth differentiation factor-15(GDF-15) and Thrombolysis in Myocardial Infarction(TIMI) risk scores in patients with unstable angina pectoris(UA).Methods The serum levels of GDF-15 in 97 patients with UA and 30 healthy volunteers were measured using enzyme-linked immunosorbent assay(ELISA) and compared between 3 patient groups with different TIMI scores to analyze relationship between serum GDF-15 levels and TIMI risk scores.Results The serum levels of GDF-15 in UA patients were significantly higher than those in the healthy volunteers(P〈0.01).GDF-15 levels also differed significantly between patients with different TIMI scores(P〈0.01),and showed a significant positive correlation to TIMI risk scores.Conclusion Serum levels of GDF-15 can be used as an index for evaluating the severity of UA.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第7期1277-1278,共2页 Journal of Southern Medical University
关键词 不稳定性心绞痛 生长分化因子15 TIMI危险评分 unstable angina pectoris growth differentiation factor-15 Thrombolysis in Myocardial Infarction risks core
  • 相关文献

参考文献7

二级参考文献50

  • 1赵明中,胡大一,陈学英,朱天刚,许玉韵.心肌梗死溶栓疗法危险评分在老年无ST段抬高急性冠状动脉综合征患者预后评估中的应用价值[J].中华医学杂志,2004,84(13):1103-1104. 被引量:6
  • 2赵树梅,李晓燕,刘现亮,刘科卫,魏敏.急性心肌梗死TIMI危险评分与冠状动脉病变的关系[J].临床心血管病杂志,2005,21(2):111-112. 被引量:8
  • 3郭永和,张维君,周玉杰,赵冬,周志明,张红.冠状动脉造影患者心血管病危险因素与冠状动脉病变程度的相关性分析[J].中华心血管病杂志,2005,33(5):415-418. 被引量:73
  • 4赵明中 胡大一 见:胡大一 马长生.不稳定心绞痛和无ST段提高心肌梗死的危险分层与处理[A].见:胡大一,马长生.心脏病学实践2002规范化治疗[C].北京:人民卫生出版社,2002.105—118.
  • 5Nicholls SJ, Hazen SL. Myeloperoxidase and cardiovascular disease[J]. Arterioscler Thromb Vase Biol, 2005, 25 ( 6 ) : 1102- 1110.
  • 6Antman EM,Cohen M,Bemink P,et al. The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making[J].JAMA, 2000, 284 : 835- 842.
  • 7Antman EM, MeCabe CH,Gurfinkel EP,et al. Enoxaparin prevents death and cardiac ischemie events in unstable angina/non-Q wavemyoeardial infarction. Results of the thrombolysis in myocardial infarction (TIMI)Ⅱ B trial [J]. Circulation, 1999,100: 1593-1601.
  • 8Scirica BM, Cannon CP, Antman EM, et al. Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI Ⅲ registry[J].Am J Cardiot, 2002,90: 303- 305.
  • 9Maseri A, Rebuzzi AG, Cianflone D. Need for a composite risk stratification of patients with unstable coronary, syndromes tailored to clinical practicer[J].Circulation, 1997,96: 4141-4142.
  • 10Braunwald E, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-ecgment elevation myocardial infarction summary article [J]. JACC, 2002,40(7) : 1366-1373.

共引文献8

同被引文献124

引证文献11

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部